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Study of Relationship between diet and exercise with lipid level in female residents
Buaijiaer Hasimu
Department of Geriatrics, BenQ Medical Center, Nanjing Medical University,
Nanjing, Jiangsu Province, China
Objectives: To evaluate the relationship between diet and exercise with blood glucose
and lipid level in female residents.
Methods: A total of 2116 people were selected from communities, each of them
undergoing the laboratory examination and dietary and exercise survey. Food fre-
quency questionnaire and physical activity questionnaire were used.
Results: The energy intakes had no signiﬁcant difference between female and male
(P>0.05)while the energy exhaust of male residents was higher than that of female resi-
dents (P<0.05),The fat intakes of female residentswerehigher than those ofmale residents
(P<0.05), while the cholesterol and dietary ﬁber intakes were lower than them (P<0.05).
Conclusions: Suitable health education should be proposed to improve female dietary
pattern and strengthen physical activity to keep ideal serum lipids.
GW25-e0719
High Brachial-ankle pulse wave velocity is a conditional factor for the
development of left ventricular remodeling: population based nested
case-control study
Wu Jing1,2, Zhang Lijuan1,2, Li Jue1,2
1Heart, Lung and Blood Vessel Center, Tongji University School of Medicine,
2Key Laboratory of Arrhythmias of Ministry of Education of China, Tongji University,
Shanghai, China
Objectives: To identify independent risk factors for new onset left ventricular (LV)
remodeling and to assess the association between brachial-ankle pulse wave velocity
(baPWV) and LV remodeling risk.
Methods:We performed a population-based, nested, case-control study of 85 subjects
with the ﬁrst time diagnosed as LV remodeling during 3-year period from May 31,
2009, through July 1, 2012. Each case were matched for 2 controls with gender, age
(1 year), identity number. LV remodeling is deﬁned as an absolute increase in LV
mass or relative wall thickness (RWT) via M-mode echocardiographic measurements.
Conditional logistic regression analysis was used to determine the effects of relevant
factors on LV remodeling.
Results: The level of baPWV is signiﬁcantly higher in case group than that in control
group (P¼0.009). Risk for LV remodeling rose markedly for subjects with
baPWV>1809.1 cm/s [OR 3.332, 95% CI 1.737-6.086]. The AUC of baPWV for LV
remodeling is 0.678. After adjustment for homocysteine (HCY), high-sensitivity
C-reactive protein (hsCRP) and dyslipidemia, Fasting plasma glucose (FPG) [OR
1.259, 95% CI 1.014-2.043], Brain natriuretic peptide (BNP>100pg/ml) [OR 2.252,
95%CI 1.337-5.909], Central blood pressure (CBP140 mmHg) [OR 1.643, 95% CI
1.022-3.695] are independently correlated with LV remodeling.
Conclusions: FPG, BNP, CBP, baPWV are independent risk factors for new onset LV
remodeling. Subjects with baPWV above 1800cm/s are tend to has higher hazard for
LV remodeling, but the ability of baPWV in diagnostic assessment is limited.
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10 years hospitalized patients situation analysis with coronary heart disease
Liu Fan, Yang Yanmei, Lu Jingchao, Yang Xiuchun
2nd hospital of Hebei medical university
Objectives: Understand the region CHD’s incidence, risk factors, diagnosis and
treatment strategies changes within the past 10 years.
Methods: 2364 cases with CHD in our hospital were study retrospectively from 2000
to 2010. According to discharge time, all cases were divided to three group ( 2000 to
2003, 2004 to 2007, 2008 to 2010), named group I, group II and group III respec-
tively. General data, risk factors, diagnosis methods and therapy strategies were
compared within three groups. Included revascularization, some medicines suggested
from guideline.
Results: (1) General data Cases in our survey were 393, 442 and 1529 patients
respectively. Mean age was 51.008.51, 66.099.26 and 65.4511.34. Gender pro-
portion, smoking history had no signiﬁcant difference within three groups. (2) History
Stable angina pectoris (SAP) was 9.7%, 4.8%, 3.1% from 2000 (group I) to 2010 (group
III). Acute coronary syndrom (ACS) was 52.1%, 49.1%, 70.3%. Old myocardial
infarction (OMI) was 28.6%, 29.9%, 11.2%. Heart failure was 30.7%, 38.8%, 42.4%.
Hypertension was 39.5%, 36.8%, 31.2% in each group. Hypertension grading had no
signiﬁcant difference. Hyperlipidemia in each group was 6.3%, 7.9%, 28.6%. The
detection rates of fasting plasma glucose in ﬁrst visit at each group were 81.5%, 83.5%,
91.4%. The detection rates of 2-hour postprandial blood glucose were 18.9%, 19.6%,
19.0%. The detection rates of glycosylated hemoglobin were 2.5%, 4.5%, 7.8%. The
detection rates of OGTT were 0.0%, 0.3%, 1.6%. Diagnosis The percentage of patients
who received diagnostic coronary angiography in each groupwas 46.2%, 36.1%, 27.6%.
Therapy The percent of LM and LAD, LCX, RCA stenosis, the proportion of stent
implantation and stent number had no signiﬁcant difference. The drog-eluting stent were
10.0%, 50.0%, 93.8% from 2000 to 2010. Patients who taking statins were 62.2%,
73.2%, 70.4%. Patients who taking dual anti-platelet medicine were 40.3%, 62.2%,
72.0%, there were signiﬁcant difference when compares with each other. The patientsC102 JACC Vol 64/16/Suppl C j October 16with hypertension who took ARB/ACEI had no signiﬁcant difference among the three
groups, the proportion of CHD patients who took CCB was 53.5%, 51.1%, 60.7%. The
patients who taking b-blocker were 64.6%, 63.0%, 81.5%.
Conclusions: From 2000 to 2010, the patients with CHD accompanied with hyper-
tension, hyperlipidemia, heart failure increased in Shijiazhuang city region. Blood
glucose detection rate increased. Severity of coronary lesions changed little, and drug
eluting stent became the mainstream of PCI therapy. The usage of statin, thermody-
namic antiplatelet, b-blocker in CHD increased gradually.
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Risk of trastuzumab-related cardiotoxicity in early breast cancer patients in
real-world setting
Xue Jian, Zhang Xiaozhong
Afﬁliated Hospital of Academy of Military Medical Sciences
Objectives: The incidence of cardiotoxicity among breast cancer patients treated by
trastuzumab outside of clinical trials is still unknown. The trastuzumab-related car-
diotoxicity raises more concerns about early breast cancer patients who are potentially
cured. We conducted an observational study to assess the incidence of cardiotoxicity
with the ﬁrst ﬁve years since the use of trastuzumab and evaluated possible risk factors
in real-world setting.
Methods: 415 patients diagnosed early breast cancer were included from January 1,
2008 to December 31, 2012. Multivariable Cox proportional hazards regression
models were used to estimate hazard ratios and 95% conﬁdence intervals with
adjustment for the possible risk factors of the trastuzumab-related cardiotoxicity.
Results: Among 415 patients (median age 49.80 range 25 to 74 years), 211 patients
(50.84%) received trastuzumab treatment, and 204 patients (49.16%) received non-
trastuzumab treatment. A total of 72 patients (17.35%) had subsequent claims for
cardiotoxicity events. Among the early breast cancer patients with trastuzumab treat-
ment, the rate of cardiotoxicity was 23.70% compared with 10.78% in non-trastuzumab
users (P<0.001). Trastuzumab users were 3.8 times more likely to develop car-
diotoxicity after adjusting for other factors (HR 3.898; 95%CI 2.31 to 6.579). Other
variables associated with increased risk of cardiotoxicity included the history of cor-
onary artery disease (HR, 2.542, 95% CI, 1.162-5.562), RT (HR 1.737; 95% CI 1.066-
2.832), the use of anthracyclines in 4 cycles (HR 1.082; 95% CI 0.500-2.341).
Conclusions: Clinical trials may underestimate the magnitude of cardiotoxicity risk
among the EBC patients with trastuzumab use in community practice. Further studies
are warranted to better deﬁne the risk factors for trastuzumab-related cardiotoxicity in
clinical practice.
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The New Body Shape Index is an Unreliable Marker for Predicting Incident
Hypertension in Chinese Adult Population from Chengdu Community
He Jiyun, He Sen, Wang Yong, Chen Xiaoping
Department of Cardiovascular Medicine, West China Hospital, Sichuan University
Objectives: Over the past three decades, numerous studies had identiﬁed that bodymass
index (BMI) or waist circumference (WC) could predict the new onset of hypertension.
However, neither BMI norWCwas a perfect indicator of perilous obesity. BMI couldn`t
distinguish between muscle and fat accumulation, and between fat locations. WC is
sensitive to body size (height and weight). Recently, Krakauer NY et al considered a
USA population sample of 14, 105 non-pregnant adults (age 18) from the National
Health and Nutrition Examination Survey (NHANES) 1999-2004 and developed A
Body Shape Index (ABSI) based on WC adjusted for height and weight (ABSI¼WC/
(BMI2/3height1/2). The new anthropometric measure could predict premature mortality
in the general population in USA, even better thanWC and BMI. SenHe et al then found
that ABSI could predict the new onset of diabetes mellitus (DM) in the Chinese popu-
lation, but the predictive ability of ABSI for DMwas not better than BMI/WC.However,
the studies of the relationships between ABSI and hypertension were sparse. Therefore,
the main aim of our study was to assess the predictive power of ABSI for hypertension.
Methods: Our study cohort is a part of the Chinese Multi-provincial Cohort Study
(CMCS).711 individuals aged 35 to 64 years were recruited from an urban community
located in Chengdu, Sichuan province and received a repeated survey in 2007.Blood
pressure, waist circumference (WC), weight, height were measured by medical pro-
fessionals. ABSI was deﬁned as WC/ (BMI2/3height1/2). Since 114 participants were
diagnosed with hypertension in 1992, they were excluded from the analysis.
This survey was approved by Ministry of Health of China, as well as by the Ethics
Committee of West China Hospital of Sichuan University. All participants provided
written informed consent.
Results: (1) Pearson correlation analysis indicated that ABSI wasn’t correlated with
SBP (r ¼0.076, P¼0.062) or DBP (r¼0.036, P¼0.374). However, both BMI and WC
were signiﬁcantly correlated with SBP (P<0.001) and DBP (P<0.001). (2) In COX
proportional hazard modeling adjusted for age, sex, TC, TG, LDL-C, HDL-C, FPG,
there wasn’t a linear relationship between ABSI and log incident hypertension
(P¼0.948). Relative to the lowest quintile, the HR of the highest quintile were 0.981
(95% CI 0.649-1.482, P¼0.926) for ABSI, compared with 2.579 (95% CI 1.693-
3.930, P<0.001) for BMI and 1.936 (95% CI 1.272-2.945, P¼0.002) for WC.
Furthermore, the log hypertension hazard didn’t increase with increasing quintile in
ABSI, neither for men (P¼0.954) nor for women (P¼0.873). (3) The area under the
receiver operating characteristic curve (AROC) was only 0.521 (95% CI 0.474-0.567,
P¼0.389) for ABSI, compared with 0.633 (95% CI 0.588-0.678, P<0.001) for BMI
and 0.618 (95% CI 0. 574-0.663, P<0.001) for WC.–19, 2014 j GW-ICC Abstracts/Epidemiology, Prevention and Control
